NEWSROOM

NASDAQ

Lipella Pharmaceuticals Initiates Phase 2a Trial for LP-310 in Oral Lichen Planus, Enrolls First Patients

Lipella Pharmaceuticals Initiates Phase 2a Trial for LP-310 in Oral Lichen Planus, Enrolls First Patients

Jul 29, 2024

Top Line Data Expected Year-End 2024 Pittsburgh, July 29, 2024 -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announced the enrollment of the first patients in its multi-center Phase 2a clinical trial evaluating LP-310 for the treatment of Oral Lichen Planus (OLP). This chronic inflammatory condition, which affects over 6 million Americans, is characterized by...

AmpliTech Group’s Division, AmpliTech Inc, Unveils Quantum Computing Cryogenic Power Supplies

Jul 25, 2024

Hauppauge, NY, July 25, 2024 – AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a leading designer, developer, and manufacturer of advanced signal processing components for satellite, 5G, and other communications networks, as well as a global distributor of integrated circuit assembly packages and lids, has announced the latest product releases from its AmpliTech Inc. division. The new Cryogenic Power Supplies are specifically designed for the quantum computing industry. Available in two models...

BranchOut Food Inc. Announces $3.925M CEO-led Investment Including an Insider PIPE and Convertible note

BranchOut Food Inc. Announces $3.925M CEO-led Investment Including an Insider PIPE and Convertible note

Jul 24, 2024

The combined $3.925M and recently completed $1.4M public offering positions the company to complete the construction of its Peru factory and achieve profitability with its current customer pipeline BEND, Ore., July 23, 2024 -- BranchOut Food Inc. (NASDAQ: BOF), a leading food technology company specializing in dehydrated fruit and vegetable-based products, today announced the closing of a $525,000 investment in company led by its CEO, Eric Healy, who invested $400,000, with Eagle Vision Fund...

Chain Bridge I to Acquire Phytanix Bio, Creating a New Public Company Focused on Developing Next Generation Cannabinoid and Cannabinoid-like Medicines

Chain Bridge I to Acquire Phytanix Bio, Creating a New Public Company Focused on Developing Next Generation Cannabinoid and Cannabinoid-like Medicines

Jul 22, 2024

Phytanix Bio is a preclinical stage pharmaceutical company founded by former members and associates of GW Pharmaceuticals, holding exclusive cannabinoid and cannabinoid-like medicine intellectual property (IP) The transaction reflects a pre-deal valuation of $58 million for Phytanix Bio plus the assumption of $17 million of preferred stock and $4.4 million of short-term debt that will be exchanged for convertible preferred stock at deal close The business combination is expected to be...

AmpliTech Group Releases Letter To Shareholders

AmpliTech Group Releases Letter To Shareholders

Jul 17, 2024

Hauppauge, NY, July 17, 2024 – AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today announced the release of a Letter to Shareholders from its CEO/CTO Mr. Fawad Maqbool. Shareholder Letter as follows: Dear...

PRISM MarketView Features Q&A with Dr. Ellen Kim: Soligenix’s HyBryte™— Lighting the Way Towards Commercial Success with Promising FLASH Study Results

PRISM MarketView Features Q&A with Dr. Ellen Kim: Soligenix’s HyBryte™— Lighting the Way Towards Commercial Success with Promising FLASH Study Results

Jul 15, 2024

NEW YORK, N.Y., July 15, 2024 – PRISM MarketView is pleased to announce an exclusive Q&A session with Dr. Ellen Kim, discussing the promising interim results of Soligenix's (Nasdaq: SNGX) HyBryte™ from the ongoing investigator-initiated study (IIS). HyBryte™ (synthetic hypericin) is a novel photodynamic therapy for the treatment of early-stage cutaneous T-cell lymphoma (CTCL), a rare form of non-Hodgkin’s lymphoma with no FDA-approved first-line treatments. Highlights from the Q&A:...

SKYX Announces Production of its New Global Patented Advanced, Smart, Plug & Play Recessed Light

SKYX Announces Production of its New Global Patented Advanced, Smart, Plug & Play Recessed Light

Jul 11, 2024

The Global Recessed Light Market is a Multi-Billion Unit Market As SKYX Continues to Grow its Market Penetration it Expects its Recessed Light to Significantly Contribute to Growth SKYX’s New Plug & Play Recessed Light Global Patents include the U.S., China, Canada, Hong-Kong and Mexico Miami, FL, July 11, 2024 – SKYX (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), a highly disruptive smart platform technology company with over 94 issued and pending...

MedTech Gurus Podcast Features Oncocyte CEO Josh Riggs in “Take Advantage of the Moment” Episode

MedTech Gurus Podcast Features Oncocyte CEO Josh Riggs in “Take Advantage of the Moment” Episode

Jul 11, 2024

HOLLAND, Mich., July 11, 2024 – MedTech Gurus, a leading podcast focused on the forefront of medical technology, featured Oncocyte Corporation (NASDAQ: OCX) CEO Josh Riggs in its latest episode, "Take Advantage of the Moment." In this episode, Riggs highlights Oncocyte's innovative strategies in molecular diagnostic technology and the significant impact of this technology on patient care. Hosted by Tom Hickey, a partner at Excelerant Consulting and a seasoned expert in medical device...

CORRECTING and REPLACING – Sono-Tek Reports 40% Increase in Sales and 525% Increase in Net Income for First Quarter Fiscal 2025

CORRECTING and REPLACING – Sono-Tek Reports 40% Increase in Sales and 525% Increase in Net Income for First Quarter Fiscal 2025

Jul 11, 2024

Provides Sales Guidance for Second Quarter of Fiscal 2025 and Anticipates Continued Sales Growth for Fiscal 2025 MILTON, N.Y., July 11, 2024 – Sono-Tek Corporation (Nasdaq: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today reported financial results for its first quarter of fiscal year 2025, ended May 31, 2024. First Quarter FY2025 Financial Highlights: (Compared with prior-year period unless otherwise noted) Net Sales for the quarter increased 40% to...

ANEW MEDICAL to Advance Patented Klotho Gene Therapy for Neurodegenerative Disorder Treatments

ANEW MEDICAL to Advance Patented Klotho Gene Therapy for Neurodegenerative Disorder Treatments

Jul 9, 2024

Genomics data suggests having an active Klotho gene sequence may help people live longer, healthier lives The Company was granted patents in Europe, China, and Hong Kong and awaits issuance of patents in the U.S. and Canada NEW YORK, July 9, 2024 -- ANEW MEDICAL, INC. (NASDAQ: WENA) (“ANEW”), a biopharmaceutical company specializing in the advancement of novel disease-modifying therapies for neurological and age-related disorders, announces plans to advance its recently patented Klotho gene...

Blackboxstocks Announces $1,250,000 Private Placement Priced at $4.00 per Share

Blackboxstocks Announces $1,250,000 Private Placement Priced at $4.00 per Share

Jul 2, 2024

Blackbox to Invest $1.15 Million into Evtec Aluminium DALLAS, July 2, 2024 – Blackboxstocks Inc. (NASDAQ: BLBX), (“Blackbox” or the “Company”), a financial technology and social media hybrid platform offering real-time proprietary analytics for stock and options traders of all levels, announced that it has closed a private placement of its common stock for aggregate proceeds in the amount of $1.25 million priced at $4.00 per share. Blackbox will invest $1.15 million into Evtec Aluminium and...

BranchOut Food Announces Closing of $1.4 Million Follow-On Public Offering

BranchOut Food Announces Closing of $1.4 Million Follow-On Public Offering

Jun 28, 2024

BEND, OR, June 28, 2024 - BranchOut Food Inc. (NASDAQ: BOF), (“BranchOut” or the “Company”), a leading food technology company specializing in dehydrated fruit and vegetable-based products, today announced the closing of its underwritten public offering of 1,750,000 shares of common stock at a public offering price of $0.80 per share. The gross proceeds from the offering, before underwriting discounts and commissions and estimated offering expenses payable by the Company, are approximately...

BranchOut Food Announces Nation’s Largest Retailer Increases Third Contract to Approximately $1M Annually, Triples Original Commitment

BranchOut Food Announces Nation’s Largest Retailer Increases Third Contract to Approximately $1M Annually, Triples Original Commitment

Jun 27, 2024

New private label dried fruit products expected to enter 3,430 stores in 2024 BEND, Ore., June 27, 2024 -- BranchOut Food Inc. (NASDAQ: BOF), a pioneering food technology company and producer of dehydrated fruit and vegetable-based products, today announced that the nation’s largest retailer has increased the store count and overall projected sales of its third contract with BranchOut Food. The new third contract now has a value of approximately $1 million in sales and is three times larger...

ANEW MEDICAL Forms Strategic Partnership with Japan’s Okinawa Research Center for Longevity Science (ORCLS) to Study Klotho Gene

ANEW MEDICAL Forms Strategic Partnership with Japan’s Okinawa Research Center for Longevity Science (ORCLS) to Study Klotho Gene

Jun 27, 2024

Collaboration focuses on research and development of ANEW’s patented Klotho gene therapy in enhancing longevity and reducing age-related diseases ANEW’s mission is to deliver transformative protein, cell, and gene therapies in areas of high unmet medical needs, particularly targeting highly prevalent neurodegenerative diseases and age-related disorders NEW YORK, June, 27. 2024 -- ANEW MEDICAL, INC. (Nasdaq: WENA), a biopharmaceutical company specializing in the advancement of novel...

BranchOut Food Prices $1.4 Million Follow-On Public Offering

BranchOut Food Prices $1.4 Million Follow-On Public Offering

Jun 26, 2024

BEND, OR, June 26, 2024 - BranchOut Food Inc. (NASDAQ: BOF) (“BranchOut” or the “Company”), a leading food technology company specializing in dehydrated fruit and vegetable-based products, today announced the pricing of its underwritten public offering of 1,750,000 shares of common stock at a public offering price of $0.80 per share. The gross proceeds from the offering, before underwriting discounts and commissions and estimated offering expenses payable by the Company, are expected to be...

BranchOut Food Ships First Production of New, Innovative Products to Nation’s Largest Retailer, Initiating Second of Three Existing Contracts Totaling $8M

BranchOut Food Ships First Production of New, Innovative Products to Nation’s Largest Retailer, Initiating Second of Three Existing Contracts Totaling $8M

Jun 26, 2024

BranchOut Food contracts with the retailer now total approximately $8 million in annualized revenue New dried vegetable offerings have shipped ahead of a nationwide launch in July 2024 BEND, Ore., June 26, 2024 -- BranchOut Food Inc. (NASDAQ: BOF), a leading food technology company specializing in dehydrated fruit and vegetable-based products, today announced it has shipped the first production of the new products that will be launched nationwide in July 2024 by the nation’s largest retailer....

ANEW MEDICAL, INC. Secures Key Patent in Europe for HUMAN Klotho Gene RNA Slice Variant and Protein

ANEW MEDICAL, INC. Secures Key Patent in Europe for HUMAN Klotho Gene RNA Slice Variant and Protein

Jun 26, 2024

ANEW to explore therapeutics and specialty diagnostics utilizing the s-KL protein and will pursue other medical product development and commercial opportunities of interest Exclusive, worldwide intellectual property licensed from Universitat Autònoma de Barcelona (UAB) and Institució Catalana de Recerca i Estudis Avançats (ICREA) in Barcelona, Spain NEW YORK, June 26, 2024 - ANEW MEDICAL, INC. (NASDAQ: WENA) (“ANEW” or “the Company”) a biopharmaceutical company specializing in the advancement...

BranchOut Food Ships First Production of New, Innovative Products to Nation’s Largest Retailer, Initiating Second of Three Existing Contracts Totaling $8M

BranchOut Food Enters the $300 Billion Industrial Food Ingredients Market

Jun 25, 2024

Industrial food ingredients expected to be a valuable additional commercialization channel Company to build out internal sales and marketing team to pursue new channel BranchOut Food will showcase its products and services at the ITF Annual Expo in July 2024 BEND, Ore., June 25, 2024 -- BranchOut Food Inc. (NASDAQ: BOF), a leading food technology company specializing in dehydrated fruit and vegetable-based products, today announced that it will enter the industrial food ingredients market as...

SKYX Announces Issuance of 6 Additional Patents in the U.S. and Globally including China, India, Europe, Canada, and Mexico for its Advanced Smart Plug & Play Ceiling Fan & Heater

SKYX Announces Issuance of 6 Additional Patents in the U.S. and Globally including China, India, Europe, Canada, and Mexico for its Advanced Smart Plug & Play Ceiling Fan & Heater

Jun 24, 2024

SKYX’s Enhances its Robust Patent Portfolio Now Totaling over 94 Issued and Pending Patents with over 36 Issued Patents in the U.S. and Globally SKYX’s Robust Patent Portfolio Includes Technologies that Enable and Enhance Performance of Smart Home and AI Sensors, in Addition to Home Safety Sensors Miami, FL, June 24, 2024 – SKYX (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), a highly disruptive smart platform technology company with over 94 issued and pending patents in the US and globally,...

U.S. Army Selects BranchOut Food Products for Field Test with Aim of Revolutionizing MREs

U.S. Army Selects BranchOut Food Products for Field Test with Aim of Revolutionizing MREs

Jun 24, 2024

Cinnamon Churro Banana Bites and Chili Lime Pineapple Chips—Both Made with GentleDry Technology—Excelled in Recent Shelf Life and Sensory Tests BEND, Ore., June 24, 2024 - BranchOut Food Inc. (NASDAQ: BOF), a pioneering food technology company and producer of dehydrated fruit and vegetable-based products, is taking the next step in its strategic collaboration with the U.S. Army Combat Capabilities Development Command (DEVCOM) to enhance Meals Ready-to-Eat (MRE) through its proprietary...

Oncocyte Appoints Andrea James as Chief Financial Officer

Oncocyte Appoints Andrea James as Chief Financial Officer

Jun 17, 2024

IRVINE, Calif., June 17, 2024 - Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today announced that it has appointed leading finance executive, Andrea James, to the position of Chief Financial Officer. “We are thrilled to welcome Andrea as we approach the inflection point of commercial launch,” Oncocyte CEO Josh Riggs said. “She has a proven track record of guiding financial strategy through multiple phases of growth, raising and stewarding capital, and building...

U.S. Army Selects BranchOut Food Products for Field Test with Aim of Revolutionizing MREs

BranchOut Food Inc. Secures Fourth EnWave Dehydration Machine for New Peru Factory with $40M Production Capacity

Jun 17, 2024

Radiant Energy Vacuum machine will be used in R&D and rapid product development to meet the needs of major retailer demands BEND, Ore., June 17, 2024 -- BranchOut Food Inc. (NASDAQ: BOF), a leading food technology company specializing in dehydrated fruit and vegetable-based products, today announced it has signed a purchase agreement for a 10kW Radiant Energy Vacuum (REV) machine, built by EnWave Corporation (TSX-V: ENW | FSE: E4U). The machine will be installed at BranchOut Food’s new,...

Breakthrough in Kidney Transplant Monitoring: PRISM MarketView Spotlights Oncocyte’s VitaGraft Study

Breakthrough in Kidney Transplant Monitoring: PRISM MarketView Spotlights Oncocyte’s VitaGraft Study

Jun 3, 2024

New York, June 3, 2024—Oncocyte’s (Nasdaq: OCX) VitaGraft Kidney™ diagnostic test for transplant monitoring has shown promising results in a Phase 2 clinical trial, published in the prestigious New England Journal of Medicine. The trial evaluated the test's effectiveness in monitoring graft health in patients with antibody-mediated rejection (AMR), a leading cause of kidney transplant failure. The study's positive outcomes highlight new clinical uses for VitaGraft Kidney, including therapeutic...

Lipella Pharmaceuticals Announces Completion of Site Initiation Visit for Phase 2a Trial of LP-310 in Oral Lichen Planus

Lipella Pharmaceuticals Announces Completion of Site Initiation Visit for Phase 2a Trial of LP-310 in Oral Lichen Planus

May 31, 2024

Clinical testing of LP-310 expected to commence in mid-2024 Patient recruitment is underway for Phase 2a multicenter, dose-ranging study PITTSBURGH, PA., May 31, 2024 -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “our,” “us” or the “Company”), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announced the successful completion of its first Site Initiation Visit (SIV) for the Phase 2a trial evaluating LP-310 in the treatment...

AmpliTech Announces Receipt of Notice from Nasdaq Regaining Compliance

AmpliTech Announces Receipt of Notice from Nasdaq Regaining Compliance

May 30, 2024

Hauppauge, NY, May 30, 2024 - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal-processing components for satellite, 5G, and other communications networks, including the design of complete 5G/6G systems, and a global distributor of packages and lids for integrated circuit assembly, announced today that it received a notice from the Nasdaq Stock Market, stating the Company has regained compliance with Nasdaq’s periodic filing...

Lipella Pharmaceuticals Announces Completion of Site Initiation Visit for Phase 2a Trial of LP-310 in Oral Lichen Planus

Lipella Pharmaceuticals Announces Abstract Publication at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

May 29, 2024

Abstract highlighting new preclinical data from LP-50 in non-muscle invasive bladder cancer PITTSBURGH, Pa., May 29, 2024 – Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “our,” “us” or the “Company”), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announces an abstract publication at the 2024 American Society of Clinical Oncology (ASCO) annual meeting, taking place from May 31 - June 4 in Chicago, IL, and online. Lipella’s...

U.S. Army Selects BranchOut Food Products for Field Test with Aim of Revolutionizing MREs

BranchOut Food Successfully Completes Key Tests with U.S. Army, Advancing MREs with GentleDry Technology

May 28, 2024

Live troop field tests mark the final phase in integrating GentleDry technology into military rations BEND, Ore., May 28, 2024 -- BranchOut Food Inc. (NASDAQ: BOF), a leading food technology company specializing in dehydrated fruit and vegetable-based products, has completed a successful shelf-life test through a strategic collaboration with the U.S. Army Combat Capabilities Development Command (DEVCOM) to enhance Meals Ready-to-Eat or MREs utilizing BranchOut Food’s proprietary GentleDry...

AmpliTech Announces Receipt of Notice from Nasdaq Regaining Compliance

AmpliTech Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

May 24, 2024

Hauppauge, NY, May 24, 2024 - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), announced today that it received a notice of non-compliance from the Nasdaq Stock Market on May 22, 2024 notifying the company that, as a result of its failure to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2024, the company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires listed companies to timely file all periodic...

U.S. Army Selects BranchOut Food Products for Field Test with Aim of Revolutionizing MREs

BranchOut Food Inc. Secures Third EnWave Dehydration Machine; Announces $40M Production Capacity with New Peru Facility

May 24, 2024

BEND, Ore., May 24, 2024 - BranchOut Food Inc. (NASDAQ: BOF), a leading food technology company specializing in dehydrated fruit and vegetable-based products, today announced the expansion of its agreement with EnWave Corporation (TSX-V: ENW | FSE: E4U). As part of this enhanced partnership, BranchOut has purchased its third large-scale EnWave dehydration machine. This addition is strategically aimed at expanding its new facility in Peru, with operations anticipated to commence in Q3,...

Sono-Tek Announces Fiscal Year 2024 Results with Record-Breaking Revenue and Record YOY Backlog

Sono-Tek Announces Fiscal Year 2024 Results with Record-Breaking Revenue and Record YOY Backlog

May 23, 2024

- Record net sales for fiscal year 2024 increased 31% - - Net income increased 127% year over year – -Provides Q1 and Full Fiscal Year 2025 Revenue Guidance – -Backlog Increased to Year-over-Year Record High – -Conference Call Thursday, May 23, 2024 at 9:30am EST – MILTON, NY, May 23, 2024 – Sono-Tek Corporation (NASDAQ: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today reported financial results for its fourth quarter and fiscal year 2024, ended February 29,...